(Q71420240)
Statements
Double-blind, placebo-controlled trial of topiramate (600 mg daily) for the treatment of refractory partial epilepsy (English)
G Pledger
R Michelucci
P Chauvel
J Chodkiewicz
S Shorvon
O Henriksen
M Dam
1 August 1996